Ecospirin (Aspirin) in Bronchial Asthma
Ecospirin should NOT be routinely prescribed to patients with bronchial asthma due to the significant risk of aspirin-exacerbated respiratory disease (AERD), which can cause severe bronchospasm, respiratory arrest, and potentially death. 1
Key Clinical Context
Aspirin and NSAIDs cause asthma exacerbations in 2-23% of adults with asthma 2, with prevalence estimates ranging from 0.07% in the general population to as high as 21% in adults with asthma 1. This is not a true IgE-mediated allergy but rather a pharmacologic reaction caused by COX-1 inhibition that shunts arachidonic acid metabolism toward excessive leukotriene production 1, 2.
Risk Stratification Algorithm
HIGH-RISK patients (AVOID aspirin completely):
- Asthma + nasal polyps
- Asthma + chronic rhinosinusitis
- Previous history of respiratory symptoms after NSAID use
- Severe or poorly controlled asthma
In these patients, aspirin can trigger violent bronchospasm, loss of consciousness, and respiratory arrest within 3 hours of ingestion 2.
LOWER-RISK patients (Use with extreme caution):
- Well-controlled asthma
- No nasal polyps
- No history of NSAID reactions
- No chronic rhinosinusitis
Even in lower-risk patients, maintain high clinical suspicion as the diagnosis is often missed due to common self-administration of aspirin 1.
Safe Alternatives
For pain/fever management:
- Acetaminophen (paracetamol) - low cross-reactivity 1
- COX-2 selective inhibitors - low cross-reactivity 1, 2
When Aspirin is Medically Necessary
If aspirin is absolutely required (e.g., for cardiovascular indications in high-risk patients), aspirin desensitization must be performed 3, 1:
Desensitization Protocol Requirements:
- Must be performed in specialized centers with experienced physicians
- Emergency treatment must be immediately available
- Pretreatment with leukotriene modifiers recommended 3
- Inhaled corticosteroid/LABA should be optimized beforehand 3
- Typical protocols start at 20.25-40.5 mg and escalate over 1-2 days 3
- Most reactions occur between 40.25-120 mg 3
Critical Maintenance Requirements:
- Minimum 325 mg daily required to maintain tolerance 3
- 650 mg twice daily typically needed for optimal control of nasal polyps and airway inflammation 3
- Gaps >48 hours may cause loss of tolerance 3
- After 5 days off aspirin, complete re-desensitization required 3
Common Pitfalls to Avoid
Topical NSAIDs are NOT safe - Medicated oils, gels, and plasters containing salicylates can trigger exacerbations through cutaneous absorption 4. A study showed significant improvement in asthma control after eliminating topical NSAID exposure (ACT scores improved from 14.9 to 22.1, p<0.05) 4.
Don't rely on history alone - While a positive history of NSAID hypersensitivity in patients with chronic rhinosinusitis and asthma has high concordance with challenge testing 5, definitive diagnosis requires controlled aspirin challenge 1.
Gastrointestinal prophylaxis - If desensitization is performed, use enteric-coated aspirin and consider PPI or H2-blockers to prevent gastritis and GI bleeding 3, 1.
Surgical planning - For patients on maintenance aspirin after desensitization who need surgery:
FDA Warning
The Ecospirin label explicitly warns: "Aspirin may cause a severe allergic reaction, which may include asthma (wheezing)" 6. The label advises asking a doctor before use if "you have asthma" 6.
Bottom Line
The default answer is NO - do not prescribe Ecospirin to asthma patients unless there is a compelling cardiovascular indication that outweighs the respiratory risks, and only after formal desensitization in a specialized center. For routine pain/fever management, use acetaminophen instead.